Teacher Retirement System of Texas boosted its holdings in Balchem Corporation (NASDAQ:BCPC - Free Report) by 11.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,896 shares of the basic materials company's stock after purchasing an additional 3,695 shares during the quarter. Teacher Retirement System of Texas owned 0.11% of Balchem worth $5,793,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Covestor Ltd raised its position in shares of Balchem by 93.8% in the 4th quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares in the last quarter. Federated Hermes Inc. acquired a new position in shares of Balchem in the 4th quarter valued at approximately $33,000. Versant Capital Management Inc raised its position in shares of Balchem by 534.2% in the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company's stock valued at $40,000 after buying an additional 203 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Balchem by 230.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock valued at $106,000 after buying an additional 450 shares in the last quarter. Finally, Huntington National Bank raised its position in shares of Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company's stock valued at $108,000 after buying an additional 156 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company's stock.
Balchem Price Performance
Shares of Balchem stock traded down $0.60 during midday trading on Thursday, hitting $161.93. 123,994 shares of the company traded hands, compared to its average volume of 163,571. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 38.83, a PEG ratio of 3.52 and a beta of 0.89. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.40 and a current ratio of 2.44. The firm's fifty day moving average price is $163.79 and its 200-day moving average price is $163.01. Balchem Corporation has a 12 month low of $145.70 and a 12 month high of $186.03.
Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). Balchem had a return on equity of 12.01% and a net margin of 14.16%. The business had revenue of $250.52 million for the quarter, compared to the consensus estimate of $245.70 million. During the same period in the previous year, the firm earned $1.03 earnings per share. The company's revenue was up 4.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Balchem Corporation will post 4.64 earnings per share for the current year.
Wall Street Analyst Weigh In
BCPC has been the topic of several research reports. Wall Street Zen lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. HC Wainwright set a $180.00 price target on shares of Balchem and gave the company a "buy" rating in a report on Monday, April 28th.
View Our Latest Research Report on BCPC
Balchem Company Profile
(
Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Further Reading

Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.